First Light Asset Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001600004

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q2 2026 · 31 positions · Total reported value $1.65B · Top-10 concentration 60.7% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 54.1% · 2 new · 12 cut · 6 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +37.7% · vs SPY +22.8% · Prev Value $1.12B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2026 13F filing, First Light Asset Management, LLC disclosed 31 equity positions with a combined reported value of $1.65B. The filing implies a focused portfolio: its ten largest positions account for 60.7% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were NEO ($179.16M), SIBN ($132.65M), AXGN ($126.95M). By sector, the heaviest allocations are Health Care 80.3%, Technology 4.2%. Versus the prior quarter, allocation shifted toward Health Care (+2.8pp) and away from Other (-2.9pp).

Versus the prior quarter, First Light Asset Management, LLC opened 2 new positions, trimmed 12 and fully exited 6, a turnover rate of 54.1% of positions. The portfolio's overlap with the prior quarter was 78% of names.

The largest new positions opened in Q2 2026 were TRVI ($39.11M), TCMD ($13.78M).

Of the 6 positions fully exited versus the prior quarter, the largest were CNTA ($62.00M), WVE ($13.37M), VERA ($12.63M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • TRVI TREVI THERAPEUTICS INC · $39.11M
  • TCMD TACTILE SYSTEMS TECHNOLOGY I · $13.78M

Fully Exited (vs previous quarter)

  • CNTA CENTESSA PHARMACEUTICALS PLC · prev qtr: $62.00M
  • WVE WAVE LIFE SCIENCES INC · prev qtr: $13.37M
  • VERA VERA THERAPEUTICS INC · prev qtr: $12.63M
  • MDXG MIMEDX GROUP INC · prev qtr: $11.23M
  • SGP SPYGLASS PHARMA INC · prev qtr: $9.72M
  • ORGO ORGANOGENESIS HOLDINGS INC · prev qtr: $8.29M

Insider Transactions (Form 4)

Latest First Light Asset Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

First Light Asset Management, LLC is an SEC-registered 13F filer based in Edina, MN, United States. As of Q2 2026 it reported 31 US equity positions with a combined value of $1.65B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: EDINA, MN, United States
  • SEC registration: 801-78528 (status: Approved), registered 2013-09-20
  • Regulatory AUM (Form ADV): $1.41B as of 2026-03-24
  • Client mix (by RAUM): pension and profit-sharing plans 71%, individual investors 29%
  • Manages 3 private funds, of which 3 hedge funds

Portfolio Structure

  • 31 positions · $1.65B reported value (Q2 2026)
  • Top 10 holdings = 60.7% of reported value
  • Largest position: NEO (NEOGENOMICS INC) at 10.9%
  • Average position size: $53.07M

Sector Tilt

  • Health Care 80.3%
  • Information Technology 5.8%
  • Industrials 3.3%
  • (classified holdings cover 89% of value)

Quarterly Activity

  • Q2 2026: 2 new, 17 added, 12 reduced, 6 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund appears to be maintaining a bullish stance on the healthcare sector, with a focus on biotechnology and pharmaceutical companies. The addition of new positions in companies like NEOGENOMICS and SI BONE INC suggests a belief in the potential growth of these sectors. 2. Key Moves: - Added: NEOGENOMICS (NEO), SI BONE INC (SIBN), APOGEE THERAPEUTICS INC (APGE), ENLIVEN THERAPEUTICS INC (ELVN), GUARDANT HEALTH INC (GH), and 908 DEVICES INC (MASS). The additions to NEOGENOMICS and SI BONE INC are significant, with NEOGENOMICS' position increasing by 26.2% and SI BONE INC by 51.8%. - Reduced: AXOGEN INC (AXGN), PALVELLA THERAPEUTICS INC (PVLA), TWIST BIOSCIENCE CORP (TWST), and AMYLYX PHARMACEUTICALS INC (AMLX). AXOGEN INC's position saw the largest reduction at 31.3%. 3. Portfolio Structure: - Passive/Active: The fund seems to be active, as it is making significant changes to its holdings, including additions and reductions. - Sector Bias: The portfolio is heavily biased towards the healthcare sector, with a particular focus on biotechnology and pharmaceuticals. - Risk Appetite: The risk appetite is moderate to high, given the significant additions to biotech and pharmaceutical companies, which are typically higher-risk investments. 4. Per-Holding One-Liner: - NEO: Biotechnology company specializing in gene editing and synthetic biology. - SIBN: Orthopedic medical device company. - AXGN: Regenerative medicine company. - APGE: Biotechnology company focused on developing therapies for rare genetic diseases. - PVLA: Biotechnology company developing treatments for rare genetic disorders. - TWST: Biotechnology company focusing on DNA synthesis and gene editing. - ELVN: Biotechnology company focused on developing therapies for neurological disorders. - GH: Diagnostic company specializing in cancer screening and monitoring. - MASS: Medical device company. - AMLX: Biotechnology company developing treatments for rare genetic diseases. 5. One-Sentence Style Summary: The First Light Asset Management fund is actively reallocating its assets towards biotechnology and pharmaceutical companies, reflecting a belief in the growth potential of these sectors while maintaining a moderate to high risk appetite.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 80.3%
Technology 4.2%
Other 10.6%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 12.28M $179.16M 10.89%
10.89%
Add
2 8.13M $132.65M 8.06%
8.06%
Add
3 2.75M $126.95M 7.72%
7.72%
Reduce
4 930.29K $123.48M 7.50%
7.50%
Add
5 771.90K $117.96M 7.17%
7.17%
Reduce
6 727.93K $74.89M 4.55%
4.55%
Reduce
7 1.36M $69.06M 4.20%
4.20%
Add
8 441.59K $66.25M 4.03%
4.03%
Add
9 6.28M $54.66M 3.32%
3.32%
Add
10 3.02M $54.30M 3.30%
3.30%
Reduce
11 783.92K $53.82M 3.27%
3.27%
Add
12 2.79M $51.13M 3.11%
3.11%
Add
13 3.38M $51.06M 3.10%
3.10%
Add
14 1.36M $50.92M 3.10%
3.10%
Add
15 2.86M $45.46M 2.76%
2.76%
Add
16 1.10M $44.50M 2.71%
2.71%
Add
17 582.00K $39.29M 2.39%
2.39%
Add
18 2.10M $39.11M 2.38%
2.38%
New
19 963.26K $32.26M 1.96%
1.96%
Add
20 6.55M $29.81M 1.81%
1.81%
Add
21 800.73K $27.52M 1.67%
1.67%
Add
22 12.81M $25.49M 1.55%
1.55%
Reduce
23 2.64M $22.25M 1.35%
1.35%
Reduce
24 246.58K $21.16M 1.29%
1.29%
Reduce
25 345.16K $20.06M 1.22%
1.22%
Add
26 167.09K $19.88M 1.21%
1.21%
Reduce
27 452.32K $18.78M 1.14%
1.14%
Reduce
28 567.84K $15.89M 0.97%
0.97%
Reduce
29 3.39M $14.23M 0.86%
0.86%
Reduce
30 462.56K $13.78M 0.84%
0.84%
New
31 85.77K $9.52M 0.58%
0.58%
Reduce

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 80% R 80% F1 80% (modelled on 2026-Q1; 8/10 hit)

Low-confidence forecast This fund replaces about 32% of its Top-10 each quarter and backtests at F1 67% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (10 quarters)

Avg precision 67% · recall 67% · F1 67% · avg rank error 3.0 · Top-10 turnover 32%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 70% 70% 70% ATEC · KRTX · XENE · CRNX · PLRX · NEO · TMDX · SIBN · FNA · ATRC CRNX · ATEC · NTRA · XENE · PLRX · TMDX · SWAV · NEO · IRTC · FNA
2024-Q2 70% 70% 70% ATEC · CRNX · NTRA · XENE · SWAV · IRTC · PLRX · TMDX · NEO · FNA FNA · ATEC · CRNX · NEO · XENE · TMDX · ATRC · PODD · CNTA · NTRA
2024-Q3 60% 60% 60% FNA · ATEC · NEO · CRNX · XENE · CNTA · PODD · ATRC · NTRA · LIVN CNTA · FNA · EVH · AXGN · ATRC · INSM · CRNX · XENE · NEO · DYN
2024-Q4 60% 60% 60% CNTA · FNA · EVH · AXGN · INSM · ATRC · DYN · TNDM · XENE · CRNX FNA · CNTA · AXGN · ATRC · TWST · VERA · NEO · XENE · CRNX · IRTC
2025-Q1 60% 60% 60% FNA · CNTA · AXGN · ATRC · TWST · VERA · NEO · XENE · IRTC · CRNX ANAB · AXGN · CNTA · NEO · TWST · HCAT · ATRC · EWTX · PHLT · IRTC
2025-Q2 90% 90% 90% ANAB · AXGN · CNTA · NEO · HCAT · TWST · EWTX · ATRC · PHLT · IRTC ANAB · CNTA · PHLT · NEO · AXGN · HCAT · TWST · ATRC · SIBN · IRTC
2025-Q3 60% 60% 60% ANAB · NEO · CNTA · PHLT · HCAT · AXGN · SIBN · TWST · ATRC · IRTC AXGN · PHLT · CNTA · NEO · AMLX · CRNX · HCAT · PVLA · TWST · LENZ
2025-Q4 60% 60% 60% AXGN · PHLT · CNTA · NEO · AMLX · CRNX · HCAT · PVLA · TWST · ORGO AXGN · NEO · SIBN · PVLA · CNTA · CRNX · ATRC · VERA · IRON · AMLX
2026-Q1 60% 60% 60% AXGN · NEO · SIBN · PVLA · CRNX · CNTA · ATRC · IRON · VERA · MDGL AXGN · PVLA · NEO · SIBN · CNTA · APGE · AMLX · TWST · CRNX · MASS
2026-Q2 ★ 80% 80% 80% PVLA · AXGN · SIBN · NEO · CNTA · APGE · AMLX · MASS · TWST · CRNX NEO · SIBN · AXGN · APGE · PVLA · TWST · ELVN · GH · MASS · AMLX

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did First Light Asset Management, LLC buy in 2026-Q2?

In its 2026-Q2 13F filing, First Light Asset Management, LLC reported 31 equity positions worth $1.65B in aggregate; its largest disclosed positions were NEO ($179.16M), SIBN ($132.65M), AXGN ($126.95M).

How large is First Light Asset Management, LLC's portfolio?

First Light Asset Management, LLC reported $1.65B of long equity holdings across 31 positions as of 2026-Q2. Top-10 holdings account for 60.7% of reported value.

What is First Light Asset Management, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/first-light-asset-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →